Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
SK bioscience Announces Approval of Its Quadrivalent Influenza Vaccine in Indonesia 2024-10-23 20:00
SK bioscience Announces Approval of Its Quadrivalent Influenza Vaccine in Indonesia 2024-10-23 15:11
Korea's SK bioscience Acquires Stake in U.S. Biotech Fina Biosolutions 2024-10-08 20:00
South Korea's SK bioscience Completes Acquisition of Germany's CDMO IDT Biologika 2024-10-02 20:00
SK bioscience Exports Influenza Vaccine to Thailand, Entering Southern Hemisphere Market 2024-03-21 13:24
SK bioscience Presents Solution for Equitable Access of Vaccine at Regionalized Vaccine Manufacturing Collaborative of World Economic Forum 2023-05-23 20:00
SK bioscience Announces the Largest Investment Ever to Establish Songdo Global Research & Process Development Center 2023-02-08 20:00
SK bioscience Introduces New Partnership Model to Establish Regional Vaccine Hubs 2023-01-27 20:00
SK bioscience Appoints New Executives to Accelerate New Growth Strategies 2023-01-20 20:00
SK bioscience's Zoster Vaccine Receives Biologics License Application Approval in Malaysia 2023-01-09 21:00
SK bioscience and CEPI Sign Agreement to Develop mRNA Vaccines 2022-10-25 20:00
SK bioscience Appoints New Executives towards Global Business Growth 2022-10-21 20:00
1